<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vangeti S</submitter><funding>DOD | Defense Health Agency</funding><funding>Swedish Research Council</funding><funding>DOD | Defense Advanced Research Projects Agency</funding><pagination>e0183722</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9769986</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(6)</volume><pubmed_abstract>We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutralization antibody titers from early (11 to 56 days) to late (4 to 8.5 months) time points postinfection. Over the study period, S1-specific IgG levels declined significantly faster than that of the S2-specific IgG. Further, serum antibodies from PCR-confirmed participants cross-recognized S2, but not S1, of the betacoronaviruses HKU1 and OC43, suggesting a greater degree of cross-reactivity of S2 among betacoronaviruses. Antibody-Dependent Natural Killer cell Activation (ADNKA) was detected at t</pubmed_abstract><journal>Microbiology spectrum</journal><pubmed_title>Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection.</pubmed_title><pmcid>PMC9769986</pmcid><funding_grant_id>N6600119C4022</funding_grant_id><funding_grant_id>2021-06713</funding_grant_id><funding_grant_id>9700130</funding_grant_id><pubmed_authors>Balinsky CA</pubmed_authors><pubmed_authors>Periasamy S</pubmed_authors><pubmed_authors>Sugiharto VA</pubmed_authors><pubmed_authors>Nunez E</pubmed_authors><pubmed_authors>Vangeti S</pubmed_authors><pubmed_authors>Marayag J</pubmed_authors><pubmed_authors>Goforth CW</pubmed_authors><pubmed_authors>George MC</pubmed_authors><pubmed_authors>Sun P</pubmed_authors><pubmed_authors>Yu XB</pubmed_authors><pubmed_authors>Marrone A</pubmed_authors><pubmed_authors>Ge Y</pubmed_authors><pubmed_authors>Soares-Schanoski A</pubmed_authors><pubmed_authors>Jani V</pubmed_authors><pubmed_authors>Schilling M</pubmed_authors><pubmed_authors>Letizia AG</pubmed_authors><pubmed_authors>Bukreyev A</pubmed_authors><pubmed_authors>Mahajan AS</pubmed_authors><pubmed_authors>Lizewski R</pubmed_authors><pubmed_authors>Marjanovic N</pubmed_authors><pubmed_authors>Ramos I</pubmed_authors><pubmed_authors>Sealfon SC</pubmed_authors><pubmed_authors>Cooper E</pubmed_authors><pubmed_authors>Porter CK</pubmed_authors><pubmed_authors>Kuzmina NA</pubmed_authors><pubmed_authors>Beckett C</pubmed_authors><pubmed_authors>Lizewski SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection.</name><description>We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutralization antibody titers from early (11 to 56 days) to late (4 to 8.5 months) time points postinfection. Over the study period, S1-specific IgG levels declined significantly faster than that of the S2-specific IgG. Further, serum antibodies from PCR-confirmed participants cross-recognized S2, but not S1, of the betacoronaviruses HKU1 and OC43, suggesting a greater degree of cross-reactivity of S2 among betacoronaviruses. Antibody-Dependent Natural Killer cell Activation (ADNKA) was detected at t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-06-12T09:51:53.933Z</modification><creation>2025-04-05T14:54:51.62Z</creation></dates><accession>S-EPMC9769986</accession><cross_references><pubmed>36374040</pubmed><doi>10.1128/spectrum.01837-22</doi></cross_references></HashMap>